Knowledge Ecology International
Attending and mending the knowledge ecosystem
Menu Close
  • About
  • Areas of work
  • Coronavirus
  • Xtandi
  • Listserves
  • Videos
  • Publications
  • Databases
  • Donate
Home»Blogs»KEI filing in ITC investigation 332–596, on COVID–19 Diagnostics and Therapeutics:, 20 March 2023

KEI filing in ITC investigation 332–596, on COVID–19 Diagnostics and Therapeutics:, 20 March 2023

Posted on March 20, 2023 by James Love

ITC-KEI-COVID-TRIPS-30March2023

Trade, WTO COVID-19, ITC, WTO, WTO TRIPS Agreement

Post navigation

KEI Comments to the NIH on Prospective Exclusive License to BrickBio Treatment for Solid Tumors
HHS and NIH reject the Xtandi March-in petition

Categories

  • About
  • Access to Knowledge
  • Access to Medicine
  • AI
  • Competition
  • Delinkage
  • Economics
  • Events
  • Evidence
  • Government Funded research
  • influence
  • Intellectual Property Rights
  • Legislation
  • Litigation
  • Lobbying
  • Marketing
  • Meetings
  • Negotiations
  • Nuclear Proliferation
  • Orphan Drugs
  • Presentations
  • Privacy
  • Public Goods
  • Research and Development
  • Site Articles
  • Timelines
  • Trade
  • Transparency
  • WHO
  • WIPO
  • WTO
© 2023 Knowledge Ecology International. All rights reserved.
Hiero by aThemes